Given the absence of male-specific screening programs, such as for the detection of prostate cancer, this collaborative research aims to increase awareness of the growing prevalence of the disease in men globally, subsequently inciting further research and action from a public health perspective.
“Alongside these factors, we forecast an increase in cancer cases globally from 10.3 million to 19 million between 2022 and 2050, as well as a projected spike in cancer-related deaths from 5.4 million to 10.5 million over the same timeframe,” he says.
“Of the 30 cancer types in the study, lung cancer will likely remain the leading type of both cases and deaths.”
With such a high indication of modifiable risk factors in male cancer patients, the research team are calling for several interventions to be made to reduce the mortality rates associated with the disease. Across the globe, greater funding and attention are required to strengthen health infrastructure, enhance workforce quality for men at risk, and improve overall access to public health education.